169 related articles for article (PubMed ID: 20332249)
1. Sleep disturbances, daytime sleepiness, and quality of life in adults with growth hormone deficiency.
Copinschi G; Nedeltcheva A; Leproult R; Morselli LL; Spiegel K; Martino E; Legros JJ; Weiss RE; Mockel J; Van Cauter E
J Clin Endocrinol Metab; 2010 May; 95(5):2195-202. PubMed ID: 20332249
[TBL] [Abstract][Full Text] [Related]
2. Impact of GH replacement therapy on sleep in adult patients with GH deficiency of pituitary origin.
Morselli LL; Nedeltcheva A; Leproult R; Spiegel K; Martino E; Legros JJ; Weiss RE; Mockel J; Van Cauter E; Copinschi G
Eur J Endocrinol; 2013 May; 168(5):763-70. PubMed ID: 23447518
[TBL] [Abstract][Full Text] [Related]
3. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
[TBL] [Abstract][Full Text] [Related]
4. Altered sleep patterns in patients with non-functional GHRH receptor.
Oliveira FT; Salvatori R; Marcondes J; Macena LB; Oliveira-Santos AA; Faro ACN; Campos VC; Oliveira CRP; Costa UMM; Aguiar-Oliveira MH
Eur J Endocrinol; 2017 Jul; 177(1):51-57. PubMed ID: 28432269
[TBL] [Abstract][Full Text] [Related]
5. Elderly people with hypothalamic-pituitary disease and growth hormone deficiency: lipid profiles, body composition and quality of life compared with control subjects.
Li Voon Chong JS; Benbow S; Foy P; Wallymahmed ME; Wile D; MacFarlane IA
Clin Endocrinol (Oxf); 2000 Nov; 53(5):551-9. PubMed ID: 11106915
[TBL] [Abstract][Full Text] [Related]
6. Effect of growth hormone replacement therapy on the quality of life in women with growth hormone deficiency who have a history of acromegaly versus other disorders.
Valassi E; Brick DJ; Johnson JC; Biller BM; Klibanski A; Miller KK
Endocr Pract; 2012; 18(2):209-18. PubMed ID: 22440981
[TBL] [Abstract][Full Text] [Related]
7. Sleep apnoea and quality of life in growth hormone (GH)-deficient adults before and after 6 months of GH replacement therapy.
Peker Y; Svensson J; Hedner J; Grote L; Johannsson G
Clin Endocrinol (Oxf); 2006 Jul; 65(1):98-105. PubMed ID: 16817827
[TBL] [Abstract][Full Text] [Related]
8. On the role of menopause for sleep-endocrine alterations associated with major depression.
Antonijevic IA; Murck H; Frieboes RM; Uhr M; Steiger A
Psychoneuroendocrinology; 2003 Apr; 28(3):401-18. PubMed ID: 12573305
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal behavior of autoimmune GH deficiency: from childhood to transition age.
De Bellis A; Bellastella G; Maiorino MI; Aitella E; Lucci E; Cozzolino D; Bellastella A; Bizzarro A; Giugliano D; Esposito K;
Eur J Endocrinol; 2016 Mar; 174(3):381-7. PubMed ID: 26598530
[TBL] [Abstract][Full Text] [Related]
10. Overweight/Obese adults with pituitary disorders require lower peak growth hormone cutoff values on glucagon stimulation testing to avoid overdiagnosis of growth hormone deficiency.
Dichtel LE; Yuen KC; Bredella MA; Gerweck AV; Russell BM; Riccio AD; Gurel MH; Sluss PM; Biller BM; Miller KK
J Clin Endocrinol Metab; 2014 Dec; 99(12):4712-9. PubMed ID: 25210883
[TBL] [Abstract][Full Text] [Related]
11. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
[TBL] [Abstract][Full Text] [Related]
12. Influences on quality of life in GH deficient adults and their effect on response to treatment.
Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Smethurst LE; Shalet SM
Clin Endocrinol (Oxf); 1999 Nov; 51(5):565-73. PubMed ID: 10594517
[TBL] [Abstract][Full Text] [Related]
13. Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy.
Janssen JA; van der Toorn FM; Hofland LJ; van Koetsveld P; Broglio F; Ghigo E; Lamberts SW; Jan van der Lely A
Eur J Endocrinol; 2001 Dec; 145(6):711-6. PubMed ID: 11720895
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
[TBL] [Abstract][Full Text] [Related]
15. Elderly people with hypothalamic-pituitary disease and untreated GH deficiency: clinical outcome, body composition, lipid profiles and quality of life after 2 years compared to controls.
Li Voon Chong JS; Groves T; Foy P; Wallymahmed ME; MacFarlane IA
Clin Endocrinol (Oxf); 2002 Feb; 56(2):175-81. PubMed ID: 11874408
[TBL] [Abstract][Full Text] [Related]
16. Neurobehavioral and quality of life changes associated with growth hormone insufficiency after complicated mild, moderate, or severe traumatic brain injury.
Kelly DF; McArthur DL; Levin H; Swimmer S; Dusick JR; Cohan P; Wang C; Swerdloff R
J Neurotrauma; 2006 Jun; 23(6):928-42. PubMed ID: 16774477
[TBL] [Abstract][Full Text] [Related]
17. GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency.
Giavoli C; Profka E; Verrua E; Ronchi CL; Ferrante E; Bergamaschi S; Sala E; Malchiodi E; Lania AG; Arosio M; Ambrosi B; Spada A; Beck-Peccoz P
J Clin Endocrinol Metab; 2012 Nov; 97(11):3983-8. PubMed ID: 22904173
[TBL] [Abstract][Full Text] [Related]
18. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
Feldt-Rasmussen U; Wilton P; Jonsson P; ;
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
[TBL] [Abstract][Full Text] [Related]
19. Unreplaced sex steroid deficiency, corticotropin deficiency, and lower IGF-I are associated with lower bone mineral density in adults with growth hormone deficiency: a KIMS database analysis.
Tritos NA; Greenspan SL; King D; Hamrahian A; Cook DM; Jönsson PJ; Wajnrajch MP; Koltowska-Häggstrom M; Biller BM
J Clin Endocrinol Metab; 2011 May; 96(5):1516-23. PubMed ID: 21367928
[TBL] [Abstract][Full Text] [Related]
20. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR
Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824
[No Abstract] [Full Text] [Related]
[Next] [New Search]
